Development of an ischemic fracture healing model in mice.
Journal
Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512
Informations de publication
Date de publication:
25 04 2022
25 04 2022
Historique:
received:
05
08
2022
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
30
4
2022
Statut:
epublish
Résumé
In fracture healing, ischemia caused by vascular injuries, chronic vascular diseases, and metabolic comorbidities is one of the major risk factors for delayed union and non-union formation. To gain novel insights into the molecular and cellular pathology of ischemic fracture healing, appropriate animal models are needed. Murine models are of particular interest, as they allow to study the molecular aspects of fracture healing due to the availability of both a large number of murine antibodies and gene-targeted animals. Thus, we present the development of an ischemic fracture healing model in mice. After inducing a mild ischemia by double ligature of the deep femoral artery in CD-1 mice, the ipsilateral femur was fractured by a 3-point bending device and stabilized by screw osteosynthesis. In control animals, the femur was fractured and stabilized without the induction of ischemia. The femora were analyzed at 2 and 5 weeks after fracture healing by means of radiology, biomechanics, histology, and histomorphometry. The surgically induced ischemia delayed and impaired the process of fracture healing. This was indicated by a lower Goldberg score, decreased bending stiffness, and reduced bone callus formation in the ischemic animals when compared with the controls. We introduce a novel ischemic femoral fracture healing model in mice, which is characterized by delayed bone healing. In future, the use of this model may allow both the elucidation of the molecular aspects of ischemic fracture healing and the study of novel treatment strategies.
Sections du résumé
BACKGROUND AND PURPOSE
In fracture healing, ischemia caused by vascular injuries, chronic vascular diseases, and metabolic comorbidities is one of the major risk factors for delayed union and non-union formation. To gain novel insights into the molecular and cellular pathology of ischemic fracture healing, appropriate animal models are needed. Murine models are of particular interest, as they allow to study the molecular aspects of fracture healing due to the availability of both a large number of murine antibodies and gene-targeted animals. Thus, we present the development of an ischemic fracture healing model in mice.
MATERIAL AND METHODS
After inducing a mild ischemia by double ligature of the deep femoral artery in CD-1 mice, the ipsilateral femur was fractured by a 3-point bending device and stabilized by screw osteosynthesis. In control animals, the femur was fractured and stabilized without the induction of ischemia. The femora were analyzed at 2 and 5 weeks after fracture healing by means of radiology, biomechanics, histology, and histomorphometry.
RESULTS
The surgically induced ischemia delayed and impaired the process of fracture healing. This was indicated by a lower Goldberg score, decreased bending stiffness, and reduced bone callus formation in the ischemic animals when compared with the controls.
INTERPRETATION
We introduce a novel ischemic femoral fracture healing model in mice, which is characterized by delayed bone healing. In future, the use of this model may allow both the elucidation of the molecular aspects of ischemic fracture healing and the study of novel treatment strategies.
Identifiants
pubmed: 35478260
doi: 10.2340/17453674.2022.2529
pmc: PMC9047454
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
466-471Références
J Orthop Res. 2019 Dec;37(12):2491-2498
pubmed: 31444806
Injury. 2008 Oct;39(10):1119-26
pubmed: 18656866
J Orthop Res. 2002 May;20(3):593-9
pubmed: 12038636
Circ Cardiovasc Interv. 2016 Feb;9(2):e001946
pubmed: 26858079
J Orthop Res. 2010 Mar;28(3):397-402
pubmed: 19780192
Circulation. 2006 Jan 3;113(1):118-24
pubmed: 16380545
Curr Osteoporos Rep. 2015 Oct;13(5):327-35
pubmed: 26254939
J Surg Res. 2008 Jun 1;147(1):84-91
pubmed: 18061614
Nature. 1961 Apr 29;190:460-1
pubmed: 13687643
Calcif Tissue Int. 2012 Jun;90(6):507-14
pubmed: 22527206
J Vasc Surg. 2004 Oct;40(4):786-95
pubmed: 15472609
Int Orthop. 2013 May;37(5):883-7
pubmed: 23392346
Life Sci. 2007 Feb 13;80(10):893-900
pubmed: 17161437
J Orthop Res. 2019 Apr;37(4):821-831
pubmed: 30835895
Eur Cell Mater. 2021 May 24;41:592-602
pubmed: 34027631
J Surg Res. 2009 May 1;153(1):71-5
pubmed: 18656902
Heart Lung Circ. 2018 Apr;27(4):427-432
pubmed: 29150158
J Cell Physiol. 2004 Jun;199(3):451-9
pubmed: 15095292
Nat Rev Rheumatol. 2015 Jan;11(1):45-54
pubmed: 25266456
J Bone Miner Res. 2005 Oct;20(10):1715-22
pubmed: 16160729
Front Cell Dev Biol. 2017 May 04;5:45
pubmed: 28523266
Contemp Orthop. 1995 Jun;30(6):489-93
pubmed: 10150380
J Orthop Res. 2004 Sep;22(5):1100-7
pubmed: 15304285
JAMA Surg. 2016 Nov 1;151(11):1070-1077
pubmed: 27551978
J Orthop Res. 2007 Jan;25(1):51-61
pubmed: 17019699
J Orthop Res. 1985;3(4):389-404
pubmed: 3906062
J Biomed Mater Res A. 2017 Mar;105(3):900-911
pubmed: 27874253